Reduced myocardial flow reserve with a CAC score of 0 on Rb-82 PET/CT in a patient with prior chemotherapy highlights cancer-therapy-related cardiotoxicity as an important differential diagnosis for microvascular disease.
Answers are grounded in this paper and cite their sources.
Isolated low MFR on Rb-82 PET/CT may indicate cancer-therapy cardiotoxicity; hypothesis-generating for microvascular assessment in survivors.
A 65-year-old woman with a history of ductal mammary carcinoma and recent autonomic dysfunction underwent a Rb-82 chloride (RbCl) cardiac PET/CT scan that showed no ischemia or scarring, but significantly reduced myocardial flow reserve (MFR) (global: 1.5) and a CAC-Score of 0. The patient's chemotherapy history (paclitaxel, carboplatin, epirubicin, pembrolizumab 2 years before) with elevated Troponin T and NT-pro-BNP levels at that time, and now reduced MFR with 0 CAC suggests cancer-therapy-related cardiotoxicity. An important differential diagnosis to the more common CAD-associated microvascular disease. Furthermore, tumor recurrence with a PET-avid lymph node metastasis was found additionally.
No takes yet. Share an insight, caveat, or question.
Pop et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: